Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Novartis (Sweden)
Täby, SueciaPublicaciones en colaboración con investigadores/as de Novartis (Sweden) (2)
2024
-
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study
Drug Design, Development and Therapy, Vol. 18, pp. 667-684
2016
-
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro
Journal of Endocrinology, Vol. 231, Núm. 2, pp. 135-145